Bismuth Subgallate
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB13909 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 14 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | heparin cofactor 2 deficiency | KG + DL |
| 2 | antithrombin deficiency type 2 | KG + DL |
| 3 | rheumatoid arthritis | KG + DL |
| 4 | factor 5 excess with spontaneous thrombosis | KG + DL |
| 5 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 6 | thrombophilia | KG + DL |
| 7 | brachydactyly-syndactyly syndrome | KG + DL |
| 8 | gout | KG + DL |
| 9 | gastroduodenitis | KG + DL |
| 10 | peptic ulcer disease | KG + DL |
| 11 | sclerosing cholangitis | KG + DL |
| 12 | bronchitis | KG + DL |
| 13 | osteoarthritis susceptibility | KG + DL |
| 14 | osteoarthritis | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.